Short-Form Ron Promotes Spontaneous Breast Cancer Metastasis through Interaction with Phosphoinositide 3-Kinase

Genes and Cancer

Volumn 2, Issue 7, 2011, Pages 753-762

  Liu, Xuemei ^a   Zhao, Ling ^a   DeRose, Yoko S ^a   Lin, Yi Chun ^a   Bieniasz, Magdalena ^a   Eyob, Henok ^a   Buys, Saundra S ^a   Neumayer, Leigh ^a   Welm, Alana L ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

breast cancer; metastasis; PI3K; Ron; short form Ron

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P85; PROTEIN TYROSINE KINASE; SHORT FORM RON PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER GROWTH; CANCER INVASION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER METASTASIS; LUNG METASTASIS; MOLECULAR DOCKING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

EID: 84863174543     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.1177/1947601911421924     Document Type: Article

References (33)

1. Bacac M,Stamenkovic I.Metastatic cancer cell.Annu Rev Pathol. 2008;3:221-47.
2. Xu AM,Huang PH.Receptor tyrosine kinase coactivation networks in cancer.Cancer Res. 2010;70 (10): 3857-60.
3. Gallego MI,Bierie B,Hennighausen L.Targeted expression of HGF/SF in mouse mammary epithelium leads to metastatic adenosquamous carcinomas through the activation of multiple signal transduction pathways.Oncogene. 2003;22 (52): 8498-508.
4. Peace BE,Toney-Earley K,Collins MH,Waltz SE.Ron receptor signaling augments mammary tumor formation and metastasis in a murine model of breast cancer.Cancer Res. 2005;65 (4): 1285-93.
5. Welm AL,Sneddon JB,Taylor C, et al.The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans.Proc Natl Acad Sci U S A. 2007;104 (18): 7570-5.
6. Maggiora P,Marchio S,Stella MC, et al.Overexpression of the RON gene in human breast carcinoma.Oncogene. 1998;16 (22): 2927-33.
7. Graveel CR,de Groot JD,Su Y, et al.Met induces diverse mammary carcinomas in mice and is associated with human basal breast cancer.Proc Natl Acad Sci U S A. 2009;106 (31): 12909-14.
8. Eder JP,Vande Woude GF,Boerner SA,LoRusso PM.Novel therapeutic inhibitors of the c-Met signaling pathway in cancer.Clin Cancer Res. 2009;15 (7): 2207-14.
9. Wagh PK,Peace BE,Waltz SE.Met-related receptor tyrosine kinase Ron in tumor growth and metastasis.Adv Cancer Res. 2008;100:1-33.
10. Kretschmann KL,Eyob H,Buys SS,Welm AL. The macrophage stimulating protein/Ron pathway as a potential therapeutic target to impede multiple mechanisms involved in breast cancer progression.Curr Drug Targets. 2010;11 (9): 1157-68.
11. Lu Y,Yao HP,Wang MH. Multiple variants of the RON receptor tyrosine kinase: biochemical properties, tumorigenic activities, and potential drug targets. Cancer Lett. 2007;257 (2): 157-64.
12. Bardella C,Costa B,Maggiora P, et al. Truncated RON tyrosine kinase drives tumor cell progression and abrogates cell-cell adhesion through E-cadherin transcriptional repression. Cancer Res. 2004;64 (15): 5154-61.
13. Nishigaki K,Hanson C,Jelacic T,Thompson D,Ruscetti S. Friend spleen focus-forming virus transforms rodent fibroblasts in cooperation with a short form of the receptor tyrosine kinase Stk. Proc Natl Acad Sci U S A. 2005;102 (43): 15488-93.
14. Persons DA,Paulson RF,Loyd MR, et al.Fv2 encodes a truncated form of the Stk receptor tyrosine kinase.Nat Genet. 1999;23 (2): 159-65.
15. Angeloni D, Danilkovitch-Miagkova A,Ivanova T,Braga E,Zabarovsky E,Lerman MI. Hypermethylation of Ron proximal promoter associates with lack of full-length Ron and transcription of oncogenic short-Ron from an internal promoter.Oncogene. 2007;26 (31): 4499-512.
16. Cardamone MD,Bardella C,Gutierrez A, et al.ERalpha as ligand-independent activator of CDH-1 regulates determination and maintenance of epithelial morphology in breast cancer cells.Proc Natl Acad Sci U S A. 2009;106 (18): 7420-5.
17. Penengo L,Rubin C,Yarden Y,Gaudino G. c-Cbl is a critical modulator of the Ron tyrosine kinase receptor.Oncogene. 2003;22 (24): 3669-79.
18. Guarino M,Rubino B,Ballabio G. The role of epithelial-mesenchymal transition in cancer pathology.Pathology. 2007;39 (3): 305-18.
19. Yilmaz M,Christofori G.EMT, the cytoskeleton, and cancer cell invasion.Cancer Metastasis Rev. 2009;28 (1-2): 15-33.
20. Vanhaesebroeck B,Alessi DR.The PI3K-PDK1 connection: more than just a road to PKB.Biochem J. 2000;346 (Pt 3): 561-76.
21. Vasudevan KM,Barbie DA,Davies MA, et al.AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer.Cancer Cell. 2009;16 (1): 21-32.
22. Ponzetto C,Bardelli A,Zhen Z, et al.A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family.Cell. 1994;77 (2): 261-71.
23. Finkelstein LD,Ney PA,Liu QP,Paulson RF,Correll PH. Sf-Stk kinase activity and the Grb2 binding site are required for Epo- independent growth of primary erythroblasts infected with Friend virus.Oncogene. 2002;21 (22): 3562-70.
24. Iwama A,Yamaguchi N,Suda T.STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family.EMBO J. 1996;15 (21): 5866-75.
25. Gelmann EP,Thompson EW,Sommers CL.Invasive and metastatic properties of MCF-7 cells and rasH-transfected MCF-7 cell lines.Int J Cancer. 1992;50 (4): 665-9.
26. Zinser GM,Leonis MA,Toney K, et al.Mammary-specific Ron receptor overexpression induces highly metastatic mammary tumors associated with beta-catenin activation.Cancer Res. 2006;66 (24): 11967-74.
27. Feres KJ,Ischenko I,Hayman MJ.The RON receptor tyrosine kinase promotes MSP-independent cell spreading and survival in breast epithelial cells. Oncogene. 2009;28 (2): 279-88.
28. Wang MH,Montero-Julian FA,Dauny I,Leonard EJ.Requirement of phosphatidylinositol-3 kinase for epithelial cell migration activated by human macrophage stimulating protein.Oncogene. 1996;13 (10): 2167-75.
29. Kim S,Welm AL,Bishop JM.A dominant mutant allele of the ING4 tumor suppressor found in human cancer cells exacerbates MYC- initiated mouse mammary tumorigenesis.Cancer Res. 2010;70 (12): 5155-62.
30. Hunter KW,Crawford NP,Alsarraj J.Mechanisms of metastasis.Breast Cancer Res. 2008;10 (Suppl 1): S2.
31. Jemal A,Tiwari RC,Murray T, et al.Cancer statistics, 2004.CA Cancer J Clin. 2004;54 (1): 8-29.
32. Micalizzi DS,Christensen KL,Jedlicka P, et al.The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling.J Clin Invest. 2009;119 (9): 2678-90.
33. Markaverich BM,Medina D,Clark JH.Effects of combination estrogen:cyclophosphamide treatment on the growth of the MXT transplantable mammary tumor in the mouse.Cancer Res. 1983;43 (7): 3208-11.